HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$1,262
-23.8%
1,732,395
+0.5%
0.26%
-21.0%
Q2 2023$1,657
-1.5%
1,724,000
-2.9%
0.32%
-10.0%
Q1 2023$1,682
-7.0%
1,775,100
-2.7%
0.36%
-17.4%
Q4 2022$1,809
-99.9%
1,823,633
+1.5%
0.44%
-11.9%
Q3 2022$1,910,000
-13.3%
1,797,190
-0.6%
0.50%
-8.8%
Q2 2022$2,202,000
-13.9%
1,808,533
-25.0%
0.54%
-34.0%
Q1 2022$2,557,000
-21.8%
2,412,116
+5.5%
0.82%
-12.0%
Q4 2021$3,269,000
-27.8%
2,286,150
+9.1%
0.94%
-35.7%
Q3 2021$4,527,000
-25.1%
2,095,900
+2.0%
1.46%
-22.7%
Q2 2021$6,044,000
-2.2%
2,055,700
+25.1%
1.88%
+31.8%
Q1 2021$6,178,000
-3.6%
1,642,959
-2.3%
1.43%
-9.4%
Q4 2020$6,407,000
+84.7%
1,681,650
-2.0%
1.58%
+63.5%
Q3 2020$3,468,000
-4.5%
1,716,600
+3.0%
0.96%
-10.7%
Q2 2020$3,632,000
+111.8%
1,666,100
+6.9%
1.08%
+62.3%
Q1 2020$1,715,000
+12.2%
1,558,900
+5.4%
0.66%
+40.0%
Q4 2019$1,529,000
-15.1%
1,479,500
-0.6%
0.48%
-23.3%
Q3 2019$1,801,000
-23.9%
1,488,810
+3.8%
0.62%
-24.0%
Q2 2019$2,366,000
-23.0%
1,434,110
+33.0%
0.81%
-24.3%
Q1 2019$3,074,000
+37.8%
1,078,610
+10.8%
1.08%
+18.6%
Q4 2018$2,230,000
-32.3%
973,682
+18.3%
0.91%
-20.2%
Q3 2018$3,293,000
-14.9%
823,223
+6.3%
1.14%
-18.7%
Q2 2018$3,871,000
+0.5%
774,258
+3.6%
1.40%
-2.8%
Q1 2018$3,850,000
+6.1%
747,481
+5.1%
1.44%
+7.6%
Q4 2017$3,627,000
+0.9%
711,185
+10.9%
1.34%
-4.6%
Q3 2017$3,596,000
-0.1%
641,011
+6.9%
1.40%
-4.2%
Q2 2017$3,598,000
+29.9%
599,600
+29.0%
1.46%
+25.6%
Q1 2017$2,770,000
-3.9%
464,750
+11.6%
1.16%
-5.3%
Q4 2016$2,882,000
-41.5%
416,500
+11.8%
1.23%
-41.9%
Q3 2016$4,927,000
+62.9%
372,677
+39.8%
2.12%
+61.6%
Q2 2016$3,024,000
+122.5%
266,658
+128.8%
1.31%
+111.0%
Q1 2016$1,359,000
+272.3%
116,550
+275.4%
0.62%
+288.1%
Q4 2015$365,000
+158.9%
31,050
+152.4%
0.16%
+142.4%
Q3 2015$141,000
-40.0%
12,300
-5.4%
0.07%
-32.7%
Q2 2015$235,000
-6.0%
13,0000.0%0.10%0.0%
Q1 2015$250,000
+42.9%
13,000
+30.0%
0.10%
+46.3%
Q4 2014$175,000
-4.4%
10,0000.0%0.07%
-5.6%
Q3 2014$183,00010,0000.07%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 739,669$13,514,0006.33%
ACK Asset Management 749,867$13,700,0004.92%
CASTLEROCK ASSET MANAGEMENT INC 26,751$489,0004.12%
GOLDMAN CAPITAL MANAGEMENT INC 309,297$5,651,0002.83%
Paradice Investment Management LLC 348,686$6,370,0001.66%
Park West Asset Management LLC 600,770$10,976,0001.62%
Adirondack Research & Management Inc. 220,638$4,031,0001.50%
RK Capital 375,043$6,852,0001.40%
KEANE CAPITAL MANAGEMENT INC 70,000$1,279,0001.23%
CARDINAL CAPITAL MANAGEMENT LLC /CT 953,618$17,423,0001.08%
View complete list of TRINITY BIOTECH PLC shareholders